Your browser doesn't support javascript.
loading
Evaluation of Standardized Usage of Oral Antidiabetic Agents in Inpatients' Prescriptions / 中国药师
China Pharmacist ; (12): 125-128, 2018.
Artículo en Chino | WPRIM | ID: wpr-705468
ABSTRACT

Objective:

To evaluate the standardized usage of oral antidiabetic agents in inpatients to provide reference for the pre -scription standardization .

Methods:

A retrospective study was used to evaluate the prescriptions of oral antidiabetic agents in inpatients during January and March in 2017 , and statistical analysis was conducted on drug usage and standardization evaluation .

Results:

There were 886 medication plans including 4,397 prescriptions, which involved in 13 kinds of antidiabetic agents .Metformin and acarbose a-gents were used most frequently .The non-standardization rate was 70.54%with 66.03%unlabeled accurate time for oral administra-tion and 4.51% labeled wrong time for oral administration .Twelve antidiabetic agents existed non-standardized applications ( >50%) .

Conclusion:

The main problem in the non-standardized usage of antidiabetic agents is leaving the special time for oral adminis -tration of antidiabetic agents out of account , which not only affect the best efficacy , but also reduce patients ' compliance .It' s neces-sary to standardize the prescriptions of antidiabetic agents to improve the standardization of medication therapy .

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Estudio observacional Idioma: Chino Revista: China Pharmacist Año: 2018 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Tipo de estudio: Estudio observacional Idioma: Chino Revista: China Pharmacist Año: 2018 Tipo del documento: Artículo